Details for New Drug Application (NDA): 015034
✉ Email this page to a colleague
NDA 015034 describes PONSTEL, which is a drug marketed by Avion Pharms and is included in one NDA. Additional details are available on the PONSTEL profile page.
The generic ingredient in PONSTEL is mefenamic acid. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
The generic ingredient in PONSTEL is mefenamic acid. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
Summary for 015034
| Tradename: | PONSTEL |
| Applicant: | Avion Pharms |
| Ingredient: | mefenamic acid |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 015034
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
